RavenQuest BioMed Solidifies Its Leadership Position in Indigenous Markets


Ryan Allway

August 22nd, 2018

Exclusive, News, Top News, Top Story


Canada’s cannabis industry is projected to be worth C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of medical and recreational cannabis. With more than 100 licensed producers, investors have many different options for gaining exposure to the burgeoning industry. The best opportunities are companies that are taking a unique approach to the market rather than simply growing cannabis flower.

RavenQuest BioMed Inc. (CSE: RQB) has developed a four pillar approach to the market, including partnerships with Indigenous Peoples, in-house licensed production by mid-2018, revenue from managed services, and research and development. Investors may want to take a closer look at the stock given its unique value proposition and focus on partnering with a growing number of Indigenous People’s groups.

Partnerships With Indigenous Peoples

Canada’s Indigenous population will play a key role in the emerging cannabis industry. While there are only four Indigenous licensed producers, and 14 applications that have identified affiliations, the government hopes to allocate about one-fifth of the total cannabis canopy to the population over the long-term. These groups are also lobbying to receive an appropriate share of the excise taxes derived from the sale of cannabis.

RavenQuest has developed an Indigenous-centered, end-to-end offering for cannabis production and sale on sovereign land. These efforts are led by Head of Government and Indigenous Relations, Bill Robinson, former President & CEO of the Alberta Gaming & Liquor Commission and former Commander, “D” division, RCMP. The company has already worked with several Indigenous Peoples groups at various stages of the licensing process.

The company’s partnerships with Indigenous populations are typically structured as a services contract to help them develop their Health Canada application. After securing licensed producer status, management’s goal is to transition into a full-fledged equity partnership focused on helping them build out their production footprint, effectively manage the operations, and realize long-term success.

New Contracts in Place

RavenQuest recently signed a contract with Alexander First Nation to develop a cannabis license application, marking a huge first step toward a brighter economic future for both the Indigenous group and the company’s shareholders. The Indigenous group is located next to the Edmonton Metro region, which has a population of over 1.3 million residents, and plans to build a cannabis facility on its sovereign land.

“This agreement speaks to our continued commitment to working with Indigenous communities,” said RavenQuest CEO George Robinson in a recent press release announcing the new agreement. “We see the economic and social impact these partnerships can bring and will continue our work in earnest to establish similar partnerships and engagements with unique Indigenous communities in the months ahead.”

In the case of Fort McMurray, the company’s services contract evolved into a full-fledged equity partnership to develop a 24,000 sq. ft. facility, and then, an expansion agreement to move it to a 250,000 sq. ft. facility. A similar agreement may be possible with Alexander First Nation if it’s successful in obtaining a licensed producer status from Health Canada, meaning that the initial agreement could be a bigger deal down the road.

These agreements also serve as a proof-of-concept when it comes to working with other Indigenous groups around the country. With one-fifth of the total canopy dedicated to these groups, they could be very lucrative over the long run.

Looking Ahead

RavenQuest BioMed Inc. (CSE: RQB) is well positioned to unlock significant value within the cannabis industry by targeting the Indigenous Peoples markets. While there are more than 100 licensed producers for investors to choose from, RavenQuest represents a unique focus that provides diversified exposure to the industry.
For more information, visit the company’s website at www.rbqglobal.com.  

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading